Drug Class: Vaccine combinations
Usual Adult Dose for Mumps Prophylaxis
0.5 mL, subcutaneously, once
Usual Adult Dose for Rubella Prophylaxis
0.5 mL, subcutaneously, once
Usual Adult Dose for Measles Prophylaxis
0.5 mL, subcutaneously, once
Usual Pediatric Dose for Mumps Prophylaxis
12 months of age and older:
0.5 mL, subcutaneously, once
Comments:
- Primary vaccination is recommended at 12 to 15 months.
- Revaccination is recommended prior to elementary school entry.
- Children vaccinated when younger than 12 months should receive another dose at 12 to 15 months of age, as well as revaccination before school entry.
Usual Pediatric Dose for Rubella Prophylaxis
12 months of age and older:
0.5 mL, subcutaneously, once
Comments:
- Primary vaccination is recommended at 12 to 15 months.
- Revaccination is recommended prior to elementary school entry.
- Children vaccinated when younger than 12 months should receive another dose at 12 to 15 months of age, as well as revaccination before school entry.
Usual Pediatric Dose for Measles Prophylaxis
12 months of age and older:
0.5 mL, subcutaneously, once
Comments:
- Primary vaccination is recommended at 12 to 15 months.
- Revaccination is recommended prior to elementary school entry.
- Children vaccinated when younger than 12 months should receive another dose at 12 to 15 months of age, as well as revaccination before school entry.
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Data not available
Dose Adjustments
Measles Outbreak Schedule:
Infants 6 to 12 months of age: If recommended by the local health authority, vaccination may occur in this age range, but should be followed up with another dose at 12 to 15 months of age, and again at 4 to 6 years of age.
Post-Exposure Vaccination:
- Vaccination after exposure to wild type measles may provide some protection if given within 72 hours of exposure.
- There is no conclusive evidence that vaccination after exposure to wild type mumps or rubella will provide protection.
Precautions
Safety and efficacy have not been established in patients younger than 12 months.
To report suspected adverse reactions, contact the Vaccine Adverse Event Reporting System (VAERS) at: https://vaers.hhs.gov
Consult WARNINGS section for additional precautions.
Dialysis
Data not available
Other Comments
Administration advice:
- The outer aspect of the upper arm is the preferred site.
- Do not administer IV.
Reconstitution/preparation techniques:
- Use only the supplied diluent.
